greeksoup/ stock research

Supernus Pharmaceuticals, Inc. 13F holders

Of the 44 funds followed here, 6 reported a position in Supernus Pharmaceuticals, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Millennium Management, 3.9 million shares worth $179.2 million, 0.1% of its reported book. Sold out: Point72 Asset Management.

FundSharesValueOf its bookChange on the quarterStatusQuarter endedFiling
Millennium Management3,853,212$179.2 million0.1%+537,239added30 June 202613F
Geode Capital Management1,570,088$73.0 million0.0%-53,426trimmed30 June 202613F
Renaissance Technologies1,478,180$68.8 million0.1%-227,042trimmed30 June 202613F
Citadel Advisors1,419,482$66.0 million0.0%-108,564trimmed30 June 202613F
Two Sigma Investments1,184,378$55.1 million0.0%+913,150added30 June 202613F
FMR LLC309,091$14.4 million0.0%+99,721added30 June 202613F
Point72 Asset Management0$00.0%-1,318,555exited30 June 202613F
Value is what the fund reported.
Read moreChange is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
6 August 202613G/AIntegrated Core Strategies (US) LLC and 7 others3.9 million6.6%30 June 2026passive, under 20% (13d-1(c))EDGAR
30 April 202613GVanguard Capital Management and 1 other2.9 million5.0%31 March 2026passive, institutional (13d-1(b))EDGAR
29 April 202613GVanguard Portfolio Management and 1 other3.3 million5.7%31 March 2026passive, institutional (13d-1(b))EDGAR
27 March 202613G/AThe Vanguard Group and 1 other00.0%13 March 2026passive, institutional (13d-1(b))EDGAR
18 February 202613G/AIntegrated Core Strategies (US) LLC and 7 others3.3 million5.7%11 February 2026passive, under 20% (13d-1(c))EDGAR
17 February 202613G/AArmistice Capital, LLC and 3 others2.8 million4.8%31 December 2025passive, institutional (13d-1(b))EDGAR
2 February 202613GMillennium Management LLC and 5 others3.0 million5.3%26 January 2026passive, under 20% (13d-1(c))EDGAR
21 January 202613G/ADimensional Fund Advisors LP and 1 other2.7 million4.7%31 December 2025passive, institutional (13d-1(b))EDGAR
14 November 202513G/AArmistice Capital, LLC and 3 others2.8 million5.1%30 September 2025passive, institutional (13d-1(b))EDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.

Fails to deliver

Settlement dateShares failedPriceFile
8 September 20269,121$43.53SEC
20 August 20261$48.54SEC
19 August 202676$49.03SEC
11 August 202613$47.07SEC
4 August 20261,428$46.00SEC
3 August 20261,206$44.63SEC
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read moreLargest in the window: 9,121 on 8 September 2026. A fail is an operational fact about settlement, not a position.

Source

Each fund's 13F-HR on EDGAR, linked per row; positions matched to SUPN by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install